This week, the FDA approved a label change on Depo Provera, requiring its maker, Pfizer, to warn women about links between use of the birth control injection and brain tumors known as meningiomas. The ...

The decision comes as Pfizer faces lawsuits from more than 1000 women who say the company knew about the risks and didn’t warn them. The agency signed off last week on a label update for 2 versions of ...

Studies show that women who use a contraceptive injection known as Depo-Provera could increase their risk of benign brain tumours by as much as 500 per cent.

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. DEPO-PROVERA contains the active ingredient medroxyprogesterone ...

Evidence indicates that Depo-Provera can cause specific mutations in women's DNA. Given the availability of alternatives without this known risk, the continued use of the shot difficult to justify.” — ...

Studies show that women who use a contraceptive injection known as Depo-Provera could increase their risk of benign brain ...

On Monday US time, Pfizer will appear in federal court in Pensacola, Florida, for a crucial hearing on whether the case — which could have a potential claim value in the billions of dollars — can ...

Have you used Depo-Provera for more than two years, and did you ever stop? Oct. 22, 2009— -- Have you used Depo-Provera for birth control for two years or more? We want to hear from you if you ...

Pfizer site manufacturing heparin active pharmaceutical ingredient. Pfizer is a pharmaceutical biotechnology corporation. U.S. government regulators have approved a new brain tumor warning for ...